CNR1 and Parkinson disease: Aberrant ECS signaling in the basal ganglia is suggested to be a culprit for PD and ligand-dependent modulation of the CBR could be one of the treatment approaches (Fernández-Ruiz, 2009; Wang et al., 2022).